Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Gut microbiota and health, and Colorectal Cancer Screening and Detection.
Review Article: TL1A Inhibitors in IBD - Mechanistic Rationale and Clinical Evidence.
The role of gastrointestinal PCR in inflammatory bowel disease flares: A double-edged sword or a diagnostic breakthrough?
Nociplastic Pain is Associated With Increased Healthcare Utilization and Lower Quality of Life in Patients With Inflammatory Bowel Disease.
Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitis.
Gut Microbiota and Extraintestinal Cancers: Mechanistic Insights and Microbiome-Targeted Interventions.
Artificial Intelligence Analysis of Endoscopy Outperforms Conventional Endoscopic Scoring for Agreement With Symptoms and Quality of Life in a Phase 3 Ulcerative Colitis Trial.
A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn's disease.
Inflammation-Induced Th17 Cells Synergize with the Inflammation-Trained Microbiota to Mediate Host Resiliency Against Intestinal Injury.
Why Symptoms Linger in Quiescent Crohn's Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways.
IL-15 Promotes Inflammatory Th17 Cells in the Intestine.
A deeper quiet: Tofacitinib and the potential of endo-histologic remission.
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience
NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024
Use of Upadacitinib in 16 Tofacitinib-refractory Ulcerative Colitis Patients: A Single-center Case 2Series.
Factors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBD
Nurturing the Gut, Moms with IBD and Their Babies.
The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD).
The Role of Tissue Biopsy in the Management of Immune Checkpoint Inhibitor Toxicity.
Mucolytic bacteria license pathobionts to acquire host-derived nutrients during dietary nutrient restriction
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study.
DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk
Fully automated endoscopic disease activity assessment in ulcerative colitis.
DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk.
Efficacy and Outcome of Tofacitinib in Immune checkpoint Inhibitor Colitis.
A potential pathogenic association between periodontal disease and Crohn's disease.
The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Addressing unmet needs from a new frontier of IBD: the South Asian IBD Alliance.
PIR-B Regulates CD4<sup>+</sup> IL17a<sup>+</sup> T-Cell Survival and Restricts T-Cell-Dependent Intestinal Inflammatory Responses.
The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis.